Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Melexis Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Melexis hat ein Gesamteigenkapital von €602.0M und eine Gesamtverschuldung von €173.5M, wodurch sich der Verschuldungsgrad auf 28.8% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €893.6M bzw. €291.6M. Melexis Das EBIT des Unternehmens beträgt €263.9M, so dass der Zinsdeckungsgrad 35.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €35.7M.

Wichtige Informationen

28.8%

Verhältnis von Schulden zu Eigenkapital

€173.48m

Verschuldung

Zinsdeckungsgrad35.5x
Bargeld€35.66m
Eigenkapital€602.00m
Gesamtverbindlichkeiten€291.57m
Gesamtvermögen€893.57m

Jüngste Berichte zur Finanzlage

Recent updates

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

May 22
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

May 08
Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Mar 27
Calculating The Fair Value Of Melexis NV (EBR:MELE)

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Mar 14
At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Feb 28
Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Feb 15
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Jan 02
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Dec 09
What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Nov 27
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Melexis (EBR:MELE) Knows How To Allocate Capital

Nov 15
Melexis (EBR:MELE) Knows How To Allocate Capital

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Nov 03
Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 10
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Sep 26
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 17
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Sep 02
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Aug 19
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Aug 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Might Become A Compounding Machine

Jul 13
Melexis (EBR:MELE) Might Become A Compounding Machine

Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Jun 29
Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

Jun 02
Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Apr 11
At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Mar 27
With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jan 09
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Dec 24
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 24
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Oct 18
Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 04
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 20
Melexis' (EBR:MELE) Dividend Will Be €0.91

We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Sep 19
We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Aug 22
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Aug 04
Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Jul 11
Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Jun 27
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Jun 13
Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Mar 01
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Feb 14
Calculating The Fair Value Of Melexis NV (EBR:MELE)

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Dec 06
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Nov 18
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 29
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 15
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around

Jul 18
Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jun 21
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Jun 08
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

Apr 11
Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?

Mar 17
What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?

Is Melexis (EBR:MELE) Likely To Turn Things Around?

Feb 28
Is Melexis (EBR:MELE) Likely To Turn Things Around?

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Feb 15
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: MELEDie kurzfristigen Aktiva des Unternehmens (€457.4M) übersteigen seine kurzfristigen Passiva (€109.6M).

Langfristige Verbindlichkeiten: MELEDie kurzfristigen Vermögenswerte des Unternehmens (€457.4M) übersteigen seine langfristigen Verbindlichkeiten (€182.0M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: MELEDie Nettoverschuldung im Verhältnis zum Eigenkapital (22.9%) wird als zufriedenstellend angesehen.

Schulden abbauen: MELEDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 10.3% auf 28.8% gestiegen.

Schuldendeckung: MELEDie Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (1.5%) gedeckt.

Zinsdeckung: Die Zinszahlungen für die Schulden von MELE sind durch das EBIT gut gedeckt (35.5x coverage).


Bilanz


Entdecken Sie finanziell stabile Unternehmen